# Bolt Biotherapeutics, Inc.: Form 8-K, filed May 11, 2023

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: 8-K
- Filed: 2023-05-11
- Accepted by EDGAR: May 11, 2023, 16:09 ET
- Period: 2023-05-11
- Accession: 0000950170-23-021225
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000095017023021225/bolt-20230511.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000095017023021225/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000095017023021225/bolt-20230511.htm

Filed May 11, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-021225. Last ingested by Listed: Nov 6, 2026, 18:52 ET. No prices; not investment advice.